Suppr超能文献

合成含吖啶磺酰胺/酰胺的新型 5-氨基-1,3,4-噻二唑-2-磺酰胺化合物及其对人碳酸酐酶 I、II、IV 和 VII 的抑制作用研究。

Synthesis of novel 5-amino-1,3,4-thiadiazole-2-sulfonamide containing acridine sulfonamide/carboxamide compounds and investigation of their inhibition effects on human carbonic anhydrase I, II, IV and VII.

机构信息

Chemistry Department, Faculty of Arts and Science, Dumlupınar University, 43100 Kütahya, Turkey.

Università degli Studi di Firenze, NEUROFARBA Dept., Sezione di Scienze Farmaceutiche e Nutraceutiche, 50019 Sesto Fiorentino, Florence, Italy.

出版信息

Bioorg Chem. 2018 Apr;77:101-105. doi: 10.1016/j.bioorg.2017.12.035. Epub 2018 Jan 2.

Abstract

Herein, we report that acridine intermediates 5 were obtained from the reduction of nitro acridine derivatives 4, which were synthesized via condensation of dimedone, p-nitrobenzaldehyde with 4-amino-N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)benzamide, respectively. Then acridine sulfonamide/carboxamide (7a-i) compounds were synthesized by reaction of amino acridine 5 with sulfonyl chlorides and carbamoyl chlorides. The new compounds were characterized by melting points, FT-IR, H NMR, C NMR and HRMS analyzes. The evaluation of in vitro test of the synthesized compounds against hCA I, II, IV and VII showed that some of them are potent inhibitors. Among them, compound 7e showed the most potent activity against hCA II with a K of 7.9 nM.

摘要

在此,我们报告说,吖啶中间体 5 是通过还原硝基吖啶衍生物 4 获得的,4 是分别通过二亚甲基酮、对硝基苯甲醛与 4-氨基-N-(5-磺酰胺基-1,3,4-噻二唑-2-基)苯甲酰胺缩合合成的。然后,吖啶磺酰胺/酰胺(7a-i)化合物通过吖啶 5 与磺酰氯和碳酰氯的反应合成。新化合物的特征在于熔点、FT-IR、H NMR、C NMR 和 HRMS 分析。对合成化合物对 hCA I、II、IV 和 VII 的体外测试评估表明,其中一些具有很强的抑制活性。其中,化合物 7e 对 hCA II 的抑制活性最强,K 值为 7.9 nM。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验